TIGIT/CD226 and CD96/CD226 gene expression ratios were substantially increased in tumor-infiltrating NK cells pre-treatment (Figures 4L and S4N), indicating a disturbed balance shifted toward NK cell inhibition. The gene discussed is CD226; the disease is neoplasm.